Cargando…

Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis

BACKGROUND: Prostate cancer (PCa) patients initiating androgen deprivation therapy (ADT) are suffering from adverse effects; exercise has been proposed as a treatment to relieve adverse effects of ADT, available meta-analysis has proved exercise improves quality of life, and therapy caused fatigue;...

Descripción completa

Detalles Bibliográficos
Autores principales: Yunfeng, Gao, Weiyang, He, Xueyang, He, Yilong, Huang, Xin, Gou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502159/
https://www.ncbi.nlm.nih.gov/pubmed/28682886
http://dx.doi.org/10.1097/MD.0000000000007368
_version_ 1783248902930038784
author Yunfeng, Gao
Weiyang, He
Xueyang, He
Yilong, Huang
Xin, Gou
author_facet Yunfeng, Gao
Weiyang, He
Xueyang, He
Yilong, Huang
Xin, Gou
author_sort Yunfeng, Gao
collection PubMed
description BACKGROUND: Prostate cancer (PCa) patients initiating androgen deprivation therapy (ADT) are suffering from adverse effects; exercise has been proposed as a treatment to relieve adverse effects of ADT, available meta-analysis has proved exercise improves quality of life, and therapy caused fatigue; recently, some high-quality trials have been conducted in order to get more assessment; we conduct an updated meta-analysis to evaluate feasibility that exercise relieves adverse effects in PCa patients initiating ADT. MATERIALS AND METHODS: A systematic article search was performed from Cochrane Library, MEDLINE, EMBASE, and PubMed databases up to March 10, 2017. Outcomes included changes in body composition, physical function, bone health and cardiometabolic changes. We conduct subgroup analysis to analyze the duration and type of exercise correlated with the effect and calculated using standard mean difference (SMD) and corresponding 95% confidence intervals (CI). RESULT: Fifteen studies involving 1135 patients were included in our meta-analysis, and significant positive effects were found in body strength (leg press (SMD: 0.78 (95%CI: 0.57–0.99, P <.00001, I(2) = 0%)), chest press (SMD: 0.71 (95%CI: 0.50–0.92, P <.00001, I(2) = 0%)), exercise tolerance (VO(2) peak SMD: 0.35 (95%CI: 0.04–0.66, P = .03, I(2) = 0%) in 6 months and SMD: 0.59 (95%CI: 0.16–1.03, P = .007, I(2) = 0% over 6 months)), fatigue (SMD: 0.84 (95%CI: −1.43 to 3.10, P = .85, I(2) = 51%) in 6 months and SMD: −9.3 (95%CI: −16.22 to −2.39, P = .0030, I(2) = 49%) over 6 months)), ADT-caused obesity (body mass index SMD: −0.33 (95%CI: −0.55 to −0.12, P = .002, I(2) = 38% in 6 months and SMD: −0.59 95%CI: −1.02 to 0.17, P = .006, I(2) = 25% over 6 months)), and sex function (SMD: 0.66 (95%CI: 0.35–0.97, P <.00001, I(2) = 2%). There were no evidence of benefit for cardiometabolic changes and bone health. No systematic difference was observed between resistance exercise training (RET) and aerobic exercise training (AET) in ADT-caused obesity, fatigue, and exercise tolerance CONCLUSION: Exercise can significantly improve the upper and lower muscle strength, increase exercise tolerance, help PCa patients receiving ADT control their body fat mass, BMI, and keep the sex function. ADT-related fatigue is correlated with exercise duration time. No differences were observed in LBM, bone mineral density, and any other metabolic blood markers. Available data show that there is no difference between AET and RET.
format Online
Article
Text
id pubmed-5502159
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-55021592017-07-18 Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis Yunfeng, Gao Weiyang, He Xueyang, He Yilong, Huang Xin, Gou Medicine (Baltimore) 7300 BACKGROUND: Prostate cancer (PCa) patients initiating androgen deprivation therapy (ADT) are suffering from adverse effects; exercise has been proposed as a treatment to relieve adverse effects of ADT, available meta-analysis has proved exercise improves quality of life, and therapy caused fatigue; recently, some high-quality trials have been conducted in order to get more assessment; we conduct an updated meta-analysis to evaluate feasibility that exercise relieves adverse effects in PCa patients initiating ADT. MATERIALS AND METHODS: A systematic article search was performed from Cochrane Library, MEDLINE, EMBASE, and PubMed databases up to March 10, 2017. Outcomes included changes in body composition, physical function, bone health and cardiometabolic changes. We conduct subgroup analysis to analyze the duration and type of exercise correlated with the effect and calculated using standard mean difference (SMD) and corresponding 95% confidence intervals (CI). RESULT: Fifteen studies involving 1135 patients were included in our meta-analysis, and significant positive effects were found in body strength (leg press (SMD: 0.78 (95%CI: 0.57–0.99, P <.00001, I(2) = 0%)), chest press (SMD: 0.71 (95%CI: 0.50–0.92, P <.00001, I(2) = 0%)), exercise tolerance (VO(2) peak SMD: 0.35 (95%CI: 0.04–0.66, P = .03, I(2) = 0%) in 6 months and SMD: 0.59 (95%CI: 0.16–1.03, P = .007, I(2) = 0% over 6 months)), fatigue (SMD: 0.84 (95%CI: −1.43 to 3.10, P = .85, I(2) = 51%) in 6 months and SMD: −9.3 (95%CI: −16.22 to −2.39, P = .0030, I(2) = 49%) over 6 months)), ADT-caused obesity (body mass index SMD: −0.33 (95%CI: −0.55 to −0.12, P = .002, I(2) = 38% in 6 months and SMD: −0.59 95%CI: −1.02 to 0.17, P = .006, I(2) = 25% over 6 months)), and sex function (SMD: 0.66 (95%CI: 0.35–0.97, P <.00001, I(2) = 2%). There were no evidence of benefit for cardiometabolic changes and bone health. No systematic difference was observed between resistance exercise training (RET) and aerobic exercise training (AET) in ADT-caused obesity, fatigue, and exercise tolerance CONCLUSION: Exercise can significantly improve the upper and lower muscle strength, increase exercise tolerance, help PCa patients receiving ADT control their body fat mass, BMI, and keep the sex function. ADT-related fatigue is correlated with exercise duration time. No differences were observed in LBM, bone mineral density, and any other metabolic blood markers. Available data show that there is no difference between AET and RET. Wolters Kluwer Health 2017-07-07 /pmc/articles/PMC5502159/ /pubmed/28682886 http://dx.doi.org/10.1097/MD.0000000000007368 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 7300
Yunfeng, Gao
Weiyang, He
Xueyang, He
Yilong, Huang
Xin, Gou
Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis
title Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis
title_full Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis
title_fullStr Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis
title_full_unstemmed Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis
title_short Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: An update meta-analysis
title_sort exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: an update meta-analysis
topic 7300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502159/
https://www.ncbi.nlm.nih.gov/pubmed/28682886
http://dx.doi.org/10.1097/MD.0000000000007368
work_keys_str_mv AT yunfenggao exerciseovercomeadverseeffectsamongprostatecancerpatientsreceivingandrogendeprivationtherapyanupdatemetaanalysis
AT weiyanghe exerciseovercomeadverseeffectsamongprostatecancerpatientsreceivingandrogendeprivationtherapyanupdatemetaanalysis
AT xueyanghe exerciseovercomeadverseeffectsamongprostatecancerpatientsreceivingandrogendeprivationtherapyanupdatemetaanalysis
AT yilonghuang exerciseovercomeadverseeffectsamongprostatecancerpatientsreceivingandrogendeprivationtherapyanupdatemetaanalysis
AT xingou exerciseovercomeadverseeffectsamongprostatecancerpatientsreceivingandrogendeprivationtherapyanupdatemetaanalysis